Results 21 to 30 of about 16,904 (296)

Clinical and immunological characteristics of Aspergillus fumigatus-sensitized asthma and allergic bronchopulmonary aspergillosis

Frontiers in Immunology, 2022
Background Aspergillus fumigatus (A.f) is a common airborne allergen that contributes to allergic asthma. In some patients, A.f can colonize in the airway and lead to allergic bronchopulmonary aspergillosis (ABPA).
Hao Chen, Xinyu Zhang, Li Zhu, Nairui An, Qing Jiang, Yaqi Yang, D. Ma, Lin Yang, R. Zhu   +8 more
semanticscholar   +1 more source

Clinical Characteristics and Prognosis of Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study

Journal of Asthma and Allergy, 2022
Background The clinical features, treatment, and prognosis of allergic bronchopulmonary aspergillosis (ABPA) are not well-defined. Objective We aimed to investigate the clinical characteristics, therapy, and prognosis of ABPA to aid its clinical ...
Yi-yan Zeng, X. Xue, H. Cai, G. Zhu, Mengchan Zhu, Jian Wang, Xixi Song, Y. Mo, Xin Gao, Jiaye Zhou, L. Ye, M. Jin   +11 more
semanticscholar   +1 more source

Critical asthma associated with allergic bronchopulmonary aspergillosis: Case report

Revista Peruana de Medicina Experimental y Salud Pública, 2020
Critical asthma syndrome is the most severe consequence of an acute asthma exacerbation. Allergic bronchopulmonary aspergillosis is one of the most frequent pathologies that mimic critical asthma syndrome and is associated with a high mortality risk when
Miguel A. Vences, Carol ManriqueVillegas, Julissa Mogollon-Lavi, Tatiana Arias-Rojas, Fernando Barriga Cari   +4 more
doaj   +1 more source

Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review

European Respiratory Review, 2022
Background Aspergillus fumigatus is a common saprophytic fungus causing allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF).
S. Manti, Alessandro Giallongo, G. Parisi, M. Papale, E. Mulé, Donatella Aloisio, N. Rotolo, S. Leonardi   +7 more
semanticscholar   +1 more source

All that glitters is not gold

Journal of Association of Pulmonologist of Tamil Nadu, 2021
In the midst of COVID pandemic, all cases presenting with lung infiltrates are assumed to be covid. However, other diagnoses are possible and a case of allergic bronchopulmonary aspergillosis which presented in the midst of the pandemic is highlighted ...
Vinod Kumar Viswanathan
doaj   +1 more source

PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosis. [PDF]

J Allergy Clin Immunol Glob
Smallwood D, Lockey RF, Kolliputi N.
europepmc   +3 more sources

Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab

Internal medicine, 2021
A 45-year-old man with allergic bronchopulmonary aspergillosis (ABPA) was treated with oral prednisolone (PSL) (30 mg/day), inhaled corticosteroids, and long-acting beta2-agonists.
Sunao Mikura, T. Saraya, Yuki Yoshida, Miku Oda, M. Ishida, Kojiro Honda, K. Nakamoto, Masaki Tamura, S. Takata, H. Shimoyamada, M. Fujiwara, H. Ishii   +11 more
semanticscholar   +1 more source

Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]

, 2016
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA, DUSE, MARZIA, Laitano, Rossella, LEONARDI, LUCIA   +3 more
core   +1 more source

Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis

Oxford Medical Case Reports, 2021
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/− oral antifungal therapy.
Muhammad Ali, O'Neil Green
semanticscholar   +1 more source

A unique case of hydropneumothorax in allergic bronchopulmonary aspergillosis

Medical Mycology Case Reports, 2019
Allergic bronchopulmonary aspergillosis (ABPA) is an immunologically mediated disease characterized by a hypersensitivity reaction to fungal colonization by Aspergillus.
Tejas Suri, Nayani Makkar, Animesh Ray, Rita Sood   +3 more
doaj   +1 more source